Documents/HHSFACA5147

FACA Committee Purpose & Justification

Strategic_Plan

Start: 2010-10-01, End: 2011-09-30, Publication: 2013-07-09

Source: http://explore.data.gov/resource/datasets/c5i3-bb9j

The information in this plan was imported from the Federal Advisory Committee Act (FACA) database and transformed into StratML Part 1, Strategic Plan, format.

Fiscal Year:2011 Committee Type: National Policy Issue Advisory Board

Submitter:

Name:Gannon (J.) Dick

Email:gannon_dick@yahoo.com

Organization:

Name:Advisory Committee on Blood Safety and Availability

Acronym:HHS

Description:
[5147]: http://www.hhs.gov/ash/bloodsafety

Stakeholder(s):

  • Department of Health and Human Services: [32]: http://www.hhs.gov/
    • Sponsoring Agency (Beneficiary)

  • John Arnold M.D.: President, Ohio Cardiac, Thoracic adn Vascular Surgeons, Inc.
    • Committee Member (Performer): Special Government Employee (SGE)

  • Frederick B Axelrod M.D,, MBA: President and CEO, LifeStream, San Bernardino, CA
    • Committee Member (Performer): Representative

  • Julie A Birkofer: Vice Preseident PPTA
    • Committee Member (Performer): Representative

  • Mr. Edward M. Burke: Hemophilia Community
    • Committee Member (Performer): Special Government Employee (SGE)

  • Alissia Cofer: Sickle Cell Community
    • Committee Member (Performer): Special Government Employee (SGE)

  • Laurence Corash M.D.: Senior VP, Medical Affairs, Chief Medical Officer, Cerus Corporation
    • Committee Member (Performer): Representative

  • Ms Mary Gustafson: Executive Director, North America
    • Committee Member (Performer): Representative

  • Charles E Haley M.D,, M.S.: Medicare Medical Director and Fiscal Intermediary Medical Director, TrailBlazer Health Enterprises, LLC
    • Committee Member (Performer): Special Government Employee (SGE)

  • Michael G Ison M.D., M.S.: Academic/Clinical, Transplantation and Immunocompromised Host, Infectious Diseases Service, Northwestern University
    • Committee Member (Performer): Special Government Employee (SGE)

  • Andra H James M.D, ,MPH: Duke Comprehensive Hemostasis and Throbosis Center, Duke Univerisity
    • Committee Member (Performer): Special Government Employee (SGE)

  • Ileanna Lopez-Plaza M.D.: Transfusion Medicine, Henry Ford Health System
    • Committee Member (Performer): Special Government Employee (SGE)

  • Jay E. Menitove M.D.: President/CEO and Medical Director Community Blood Center of Kansas City
    • Committee Member (Performer): Representative

  • Klaus Nether: Associate Project Director, Division of Standards and Survey Methods, The Joint Commission
    • Committee Member (Performer): Representative

  • Gregory J Pomper M.D.: Assistant Professor of Pathology, Wake Forest university School of Medicine, Department of Pathology, Med8ical Center Boulevard, Winston-Salem, NC
    • Committee Member (Performer): Special Government Employee (SGE)

  • Karen Quillen M.D.: Boston Medical Center Transfusion Medical Director
    • Committee Member (Performer): Special Government Employee (SGE)

  • Professor Ravindra Sarode M.D.: Professor and Director, Transfusion Medicine and Hemostasis Lab, Southwestern Med Center, Dallas, TX
    • Committee Member (Performer): Special Government Employee (SGE)

  • Aryeh Shander M.D, FCCM,: Chief, Department of Anesthesiology, Englewood Hospital and Med Center, Englewood, NJ
    • Committee Member (Performer): Special Government Employee (SGE)

  • Mr. Richard Vogel: Consumer
    • Committee Member (Performer): Special Government Employee (SGE)

  • Roslyn Yomtovian M.D.: VA National Quality Scholar Fellow
    • Committee Member (Performer): Regular Government Employee (RGE)